2 results match your criteria: "Australia. Electronic address: skotwal@georgeinstitute.org.au.[Affiliation]"
Implementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management.
Heart Lung Circ
August 2025
Department of Nephrology, Prince of Wales Hospital, Sydney, NSW, Australia; Renal and Metabolic Division, The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia. Electronic address:
Cardiovascular-kidney-metabolic (CKM) syndrome is a newly defined health syndrome, encompassing the overlapping pathophysiology and risk factors of cardiovascular and kidney disease, obesity, and type 2 diabetes. It is the leading cause of morbidity and mortality worldwide, with an annual health cost of approximately AUD $24 billion in Australia alone. A disproportionate burden is observed among those with adverse social determinants of health.
View Article and Find Full Text PDFLong-term Outcomes of Patients with Acute Myocardial Infarction Presenting to Regional and Remote Hospitals.
Heart Lung Circ
February 2016
The George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Background: Acute myocardial infarction (AMI) has poorer outcomes in disadvantaged populations such as those in regional and remote locations. We compared long-term outcomes associated with presentation to regional or remote hospitals among AMI patients.
Methods And Results: Administrative claims data from New South Wales (27% regional and remote residents) was used to identify patients >18 years admitted to any NSW hospital with a principal diagnosis of AMI (ICD10 codes: I21·0-I21·4) between 01/07/2004 and 30/06/2008.